Business Description
Baijin Life Science Holdings Ltd
NAICS : 339910
SIC : 3915
ISIN : KYG0130B1014
Total Employee Number:
79Compare
Compare
Traded in other countries / regions
01466.Hong KongMNNGF.USA IPO Date
2014-10-17Description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewellery business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewellery business segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.52 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.87 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 5.63 | |||||
Beneish M-Score | -1.49 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.7 | |||||
3-Year FCF Growth Rate | 11.4 | |||||
3-Year Book Growth Rate | 17.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 75.74 | |||||
9-Day RSI | 63.5 | |||||
14-Day RSI | 58.8 | |||||
3-1 Month Momentum % | 123.53 | |||||
6-1 Month Momentum % | 111.11 | |||||
12-1 Month Momentum % | 62.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.97 | |||||
Quick Ratio | 2.07 | |||||
Cash Ratio | 0.67 | |||||
Days Inventory | 292.84 | |||||
Days Sales Outstanding | 80.58 | |||||
Days Payable | 38.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.4 | |||||
Shareholder Yield % | 0.25 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 7.46 | |||||
Operating Margin % | -53.03 | |||||
Net Margin % | -42.4 | |||||
EBITDA Margin % | -36.53 | |||||
FCF Margin % | -25.45 | |||||
OCF Margin % | -8.21 | |||||
ROE % | -24.41 | |||||
ROA % | -13.58 | |||||
ROIC % | -22.96 | |||||
3-Year ROIIC % | -38.3 | |||||
ROC (Joel Greenblatt) % | -54.62 | |||||
ROCE % | -18.96 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 11 | |||||
PB Ratio | 5.4 | |||||
Price-to-Tangible-Book | 6 | |||||
EV-to-EBIT | -22.52 | |||||
EV-to-EBITDA | -29.2 | |||||
EV-to-Revenue | 10.67 | |||||
EV-to-FCF | -41.91 | |||||
Price-to-GF-Value | 2.51 | |||||
Price-to-Projected-FCF | 108 | |||||
Price-to-Median-PS-Value | 2.7 | |||||
| Price-to-Net-Current-Asset-Value | 9 | |||||
Earnings Yield (Greenblatt) % | -4.44 | |||||
FCF Yield % | -2.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baijin Life Science Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 89.304 | ||
| EPS (TTM) (HK$) | -0.057 | ||
| Beta | -0.0987 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 79.83 | ||
| 14-Day RSI | 58.8 | ||
| 14-Day ATR (HK$) | 0.081602 | ||
| 20-Day SMA (HK$) | 0.98425 | ||
| 12-1 Month Momentum % | 62.86 | ||
| 52-Week Range (HK$) | 0.465 - 1.7 | ||
| Shares Outstanding (Mil) | 932.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baijin Life Science Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baijin Life Science Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2025 | 2024-11-29 | 0.53 (+0.00%) | ||
| 0.1:1 Stock Split | 2020-09-07 | 0.22 (+0.00%) | ||
| 5:1 Stock Split | 2018-10-02 | 14.22 (-0.27%) |
Show
Entries
Baijin Life Science Holdings Ltd Frequently Asked Questions
What is Baijin Life Science Holdings Ltd(HKSE:01466)'s stock price today?
The current price of HKSE:01466 is HK$1.08. The 52 week high of HKSE:01466 is HK$1.70 and 52 week low is HK$0.47.
When is next earnings date of Baijin Life Science Holdings Ltd(HKSE:01466)?
The next earnings date of Baijin Life Science Holdings Ltd(HKSE:01466) is .
Does Baijin Life Science Holdings Ltd(HKSE:01466) pay dividends? If so, how much?
Baijin Life Science Holdings Ltd(HKSE:01466) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Baijin Life Science Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers